enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. What's the strongest OTC anti-inflammatory? Experts ... - AOL

   www.aol.com/whats-strongest-otc-anti...

   Naproxen is considered to be the strongest anti-inflammatory medication available over the counter, says Walia. ... stomach ulcers, Crohn’s disease or ulcerative colitis ... Shop the best New ...

3. FDA-approved drug for ulcerative colitis also effective for ...

   www.aol.com/fda-approved-drug-ulcerative-colitis...

   Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, also sends Crohn's disease into clinical remission, new findings suggest.

4. Targeted therapy may help treat moderate to severe ulcerative ...

   www.aol.com/targeted-therapy-may-help-treat...

   “There has been a great deal of progress in developing new, more effective and safe agents to treat inflammatory bowel diseases (Crohn’s disease and ulcerative colitis) over the last 20 years.

5. Mirikizumab - Wikipedia

   en.wikipedia.org/wiki/Mirikizumab

   Mirikizumab was developed by Eli Lilly and Company. [10]The approval was based on the LUCENT 1 clinical study which evaluated the safety and efficacy of mirikizumab in participants with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to, loss of response, or intolerant to conventional or biologic therapy for UC.

6. Etrasimod - Wikipedia

   en.wikipedia.org/wiki/Etrasimod

   Etrasimod, sold under the brand name Velsipity, is a medication that is used for the treatment of ulcerative colitis. [6] It is a selective sphingosine-1-phosphate (S1P) receptor modulator that modifies the activity of the immune system. [6] It is taken by mouth. [6] The most common side effects include lymphopenia (low levels of lymphocytes ...

7. MK-7240 - Wikipedia

   en.wikipedia.org/wiki/MK-7240

   MK-7240 (formerly PRA-023) is a humanized monoclonal antibody developed for ulcerative colitis and Crohn's disease. [ 1 ] [ 2 ] [ 3 ] Before the company was acquired by Merck for $10.8 billion, it was developed by Prometheus Biosciences.

8. Vedolizumab - Wikipedia

   en.wikipedia.org/wiki/Vedolizumab

   Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Takeda Oncology for the treatment of ulcerative colitis and Crohn's disease. [5] It binds to integrin α 4 β 7 ( LPAM-1 , lymphocyte Peyer's patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7 ), [ 5 ] [ 6 ] blocking the α 4 ...

9. Sulfasalazine - Wikipedia

   en.wikipedia.org/wiki/Sulfasalazine

   Sulfasalazine, sold under the brand name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. [5] It is considered by some to be a first-line treatment in rheumatoid arthritis. [6] It is taken by mouth or can be administered rectally. [5]